A critical breakthrough in cancer research is arising with the use of mini-antibodies to restore dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in many kinds of tumors, resulting https://telebookmarks.com/story12601164/vhh-fragments-revive-tumor-suppressor-p53-the-potential-pathway-for-malignant-treatment